Form 8-K - Current report:
SEC Accession No. 0001437749-25-008834
Filing Date
2025-03-24
Accepted
2025-03-24 07:15:13
Documents
35
Period of Report
2025-03-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20250321c_8k.htm   iXBRL 8-K 25509
2 EXHIBIT 99.1 ex_793260.htm EX-99.1 12449
7 moleculin.jpg GRAPHIC 17262
8 slide1.jpg GRAPHIC 77566
9 slide2.jpg GRAPHIC 98994
10 slide3.jpg GRAPHIC 63875
11 slide4.jpg GRAPHIC 68769
12 slide5.jpg GRAPHIC 89145
13 slide6.jpg GRAPHIC 74212
14 slide7.jpg GRAPHIC 63159
15 slide8.jpg GRAPHIC 83897
16 slide9.jpg GRAPHIC 74201
17 slide10.jpg GRAPHIC 62805
18 slide11.jpg GRAPHIC 59743
19 slide12.jpg GRAPHIC 71202
20 slide13.jpg GRAPHIC 57948
21 slide14.jpg GRAPHIC 77870
22 slide15.jpg GRAPHIC 64475
23 slide16.jpg GRAPHIC 55112
24 slide17.jpg GRAPHIC 67932
25 slide18.jpg GRAPHIC 73625
26 slide19.jpg GRAPHIC 75033
  Complete submission text file 0001437749-25-008834.txt   2100731

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20250324.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20250324_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20250324_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20250324_pre.xml EX-101.PRE 12022
37 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20250321c_8k_htm.xml XML 2946
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 25762210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)